{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:58:39Z","timestamp":1790114319061,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ejca.2020.03.007","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T18:00:52Z","timestamp":1587664852000},"page":"100-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Direct-to-consumer misleading information on cancer risks calls for an urgent clarification of health genetic testing performed by commercial companies"],"prefix":"10.1016","volume":"132","author":[{"given":"Antoine","family":"de Pauw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystelle","family":"Colas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Golmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Stoppa-Lyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2020.03.007_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS recommendations for the description of sequence variants: 2016 update","volume":"37","author":"den Dunnen","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ejca.2020.03.007_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s004399900153","article-title":"The identical 5\u2019 splice-site acceptor mutation in five attenuated APC families from Newfoundland demonstrates a founder effect","volume":"105","author":"Spirio","year":"1999","journal-title":"Hum Genet"},{"key":"10.1016\/j.ejca.2020.03.007_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/348747a0","article-title":"Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li\u2013Fraumeni syndrome","volume":"348","author":"Srivastava","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2020.03.007_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12687-017-0344-2","article-title":"Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape","volume":"9","author":"Kalokairinou","year":"2018","journal-title":"J Community Genet"},{"key":"10.1016\/j.ejca.2020.03.007_bib5","doi-asserted-by":"crossref","first-page":"l5688","DOI":"10.1136\/bmj.l5688","article-title":"Direct-to-consumer genetic testing","author":"Horton","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2020.03.007_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1748-720X.2009.00380.x","article-title":"Currents in contemporary ethics direct-to-consumer genetic testing: is it the practice of medicine?","volume":"37","author":"Marietta","year":"2009","journal-title":"J Law Med Ethics"},{"key":"10.1016\/j.ejca.2020.03.007_bib7","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/ejhg.2010.129","article-title":"Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes","volume":"18","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ejca.2020.03.007_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/gim.2015.190","article-title":"Direct-to-consumer genetic testing: a revised position statement of the American College of Medical Genetics and Genomics","volume":"18","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.ejca.2020.03.007_bib9","series-title":"The British society for genetic medicine. Position statement on Direct to consumer genomic testing","year":"2019"},{"key":"10.1016\/j.ejca.2020.03.007_bib10","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/gim.2018.38","article-title":"False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care","volume":"20","author":"Tandy-Connor","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.ejca.2020.03.007_bib11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.aaz6732","article-title":"When health tech companies change their terms of service","volume":"367","author":"Roberts","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejca.2020.03.007_bib12","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1200\/JCO.2016.71.6480","article-title":"Gaps in incorporating germline genetic testing into treatment decision-making for early-stage breast cancer","volume":"35","author":"Kurian","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.03.007_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.breast.2019.01.002","article-title":"\u201cDecoding hereditary breast cancer\u201d benefits and questions from multigene panel testing","volume":"45","author":"Colas","year":"2019","journal-title":"Breast"},{"key":"10.1016\/j.ejca.2020.03.007_bib14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.2019.10987","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA -related cancer: US preventive services Task Force recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejca.2020.03.007_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2018.09.019","article-title":"European Breast Cancer Council manifesto 2018: genetic risk prediction testing in breast cancer","volume":"106","author":"Rutgers","year":"2019","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2020.03.007_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41436-018-0028-2","article-title":"Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework","volume":"21","author":"Green","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.ejca.2020.03.007_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/humu.21628","article-title":"ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes","volume":"33","author":"Spurdle","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ejca.2020.03.007_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gepi.20074","article-title":"A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes","volume":"29","author":"Antoniou","year":"2005","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.ejca.2020.03.007_bib19","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1053\/gast.1997.v113.pm9322509","article-title":"Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The international collaborative group on hereditary nonpolyposis colorectal cancer","volume":"113","author":"Peltomaki","year":"1997","journal-title":"Gastroenterology"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920301489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920301489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:27:39Z","timestamp":1760732859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920301489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":19,"alternative-id":["S0959804920301489"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.03.007","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct-to-consumer misleading information on cancer risks calls for an urgent clarification of health genetic testing performed by commercial companies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}